Status:
RECRUITING
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy
Lead Sponsor:
N.N. Petrov National Medical Research Center of Oncology
Conditions:
Soft Tissue Sarcoma Adult
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Combined treatment of soft tissue sarcoma includes 3 steps: 1. step - preoperative stereotactic radiation therapy in hypofractionation mode 2. step - operation 3. step - postoperative conformal radia...
Detailed Description
Combined treatment of soft tissue sarcoma includes 3 steps: 1. At the first step patient undergoes preoperative stereotactic radiation therapy in hypofractionation mode. Radiation therapy plan is bas...
Eligibility Criteria
Inclusion
- morphologically verified diagnosis of soft tissue sarcoma
- first diagnosed tumor process
- ability to perform radical surgery
- signed informed consent
- indications for stereotactic and conformal radiation therapy
- no contraindications for radiation and surgical treatment
Exclusion
- previous radiation treatment
- acute infection
- pregnancy, lactation
- recurrent tumor
- refuse to sign informed consent
- conditions that can affect the outcome of treatment (immunodeficiency, tuberculosis, etc.)
- tumor topography and volume that don't allow to perform stereotactic and conformal radiation therapy.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04330456
Start Date
February 1 2020
End Date
July 1 2028
Last Update
April 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Research Center of Oncology named after N.N.Petrov
Saint Petersburg, Russia